NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/20/2025
Back to search
Official data from USPTO
LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) INJECTION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
56
Latest update
12/09/2025
Trademark type
Combined
Nice classes
5
Filing date
09/04/2013
Registration date
08/25/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/20/2025
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/13/2013
First use in commerce
03/13/2013
Drawing code
3
Owner type
16
Owner location
DUBLIN, OH
Examiner
MARCY,AMY ALFIERI
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "LYMPHOSEEK" followed by a diamond design with arrows at each corner of the design all appearing above the wording "(TECHNETIUM TC 99M TILMANOCEPT) INJECTION".
Holders and representatives
Holders
CARDINAL HEALTH 414, LLC
Navidea Biopharmaceuticals, Inc.
Representatives
N. Christopher Norton ArentFox Schiff LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Radiolabelled lymphatic tissue reagents for clinical use containing in substantial part tilmanocept
Publications
History of USPTO decisions and trademark events.
56 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/20/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/20/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/20/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
08/06/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/25/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/29/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/29/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/22/2021
E815
TEAS SECTION 8 & 15 RECEIVED
08/19/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/25/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/04/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/03/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/12/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/12/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
08/25/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/24/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/23/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/08/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/07/2015
IUAF
USE AMENDMENT FILED
06/09/2015
EISU
TEAS STATEMENT OF USE RECEIVED
06/09/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2015
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/27/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/02/2014
PUBO
PUBLISHED FOR OPPOSITION
12/02/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/12/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/25/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/20/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/10/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/06/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/22/2014
GNRT
NON-FINAL ACTION E-MAILED
08/22/2014
CNRT
NON-FINAL ACTION WRITTEN
08/22/2014
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/17/2014
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/29/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/13/2014
ALIE
ASSIGNED TO LIE
06/10/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/27/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
05/27/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/27/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
05/27/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/27/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/23/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/23/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/23/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/30/2013
GNRT
NON-FINAL ACTION E-MAILED
12/30/2013
CNRT
NON-FINAL ACTION WRITTEN
12/30/2013
DOCK
ASSIGNED TO EXAMINER
12/16/2013
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/13/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2013
NWAP
NEW APPLICATION ENTERED
09/07/2013
Continuous trademark protection
Get notified about every new filing that threatens LYMPHOSEEK (TECHNETIUM TC 99M TILMANOCEPT) INJECTION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.